Form4insider filings, from the source

Company · CIK 0001867096 · SIC 2834 — Pharmaceutical Preparations · Nasdaq

Xeris Biopharma Holdings, Inc. · XERS

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $0 · 0sales $1.8M · 9net −$1.8M
$10k$10k$100k$100k$1M$1MbuyssalesJun 28Jul 13Jul 28Aug 13Aug 28Sep 13Sep 28

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Sep 1, 2026 SForm 4 →Sep 1, 6:21 pm EDTKevin McCullochSee Remarks15,000$8.49$127,3081,639,208−0.91%10b5-1
Sep 1, 2026 SForm 4 →Sep 1, 6:21 pm EDTBeth HechtSee Remarks16,666$8.49$141,4341,127,796−1.46%10b5-1
Sep 1, 2026 SForm 4 →Sep 1, 6:20 pm EDTSteven PieperSee Remarks5,000$8.50$42,5001,356,053−0.37%10b5-1
Aug 12, 2026 SForm 4 →Aug 12, 4:44 pm EDTSteven PieperSee Remarks5,000$8.50$42,5001,361,053−0.37%10b5-1
Aug 3, 2026 SForm 4 →Aug 4, 5:30 pm EDTKevin McCullochSee Remarks15,000$8.02$120,2401,676,126−0.89%10b5-1
Aug 3, 2026 SForm 4 →Aug 4, 5:16 pm EDTBeth HechtSee Remarks16,666$8.01$133,5531,144,462−1.44%10b5-1
Aug 1, 2026 FForm 4 →Aug 21, 4:23 pm EDTJohn Patrick Shannon Jr.See Remarks, Director36,645$8.08$296,0922,898,933— late
Aug 1, 2026 FForm 4 →Aug 21, 4:15 pm EDTKevin McCullochSee Remarks21,918$8.08$177,0971,654,208— late
Jul 6, 2026 SForm 4 →Jul 7, 5:11 pm EDTSteven PieperSee Remarks45,000$8.52$383,1761,366,053−3.19%10b5-1
Jul 1, 2026 AForm 4 →Jul 2, 6:01 pm EDTNerissa KreherDirector33,582——33,582—
Jul 1, 2026 SForm 4 →Jul 2, 4:40 pm EDTKevin McCullochSee Remarks90,000$8.03$722,5111,691,126−5.05%10b5-1
Jul 1, 2026 SForm 4 →Jul 2, 4:38 pm EDTBeth HechtSee Remarks16,666$8.03$133,8601,161,128−1.42%10b5-1

Reported at this company — derivatives (options, RSUs, warrants)

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Jul 1, 2026 AForm 4 →Jul 2, 6:01 pm EDTNerissa KreherDirector37,910$8.00$303,28037,910—